6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy
Accreditation: 10.25 AMA PRA Category 1 Credit™ | 10.25 ABIM MOC II | 10.25 Nursing Contact Hours | 10.25 ACPE Pharmacy
Venue: Hyatt Regency San Francisco Downtown SOMA, 50 3rd Street, San Francisco, CA, 94103, United States
Official conference page for 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy. https://binaytara.org/projects/conferences/6th-binaytara-precision-oncology-summit-at-the-forefront-of-targeted-cancer-therapy
About 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Agenda
Day 1: Friday, September 11th, 2026
All timings are in Pacific Time (PDT, GMT-07:00) time.
10:00 AM - 10:30 AM
Target Discovery and Validation – Dennis Slamon, MD, PhD
Session Chair: Pamela Munster, MD
10:30 AM - 10:45 AM
Overview of germline vs. somatic mutations in cancer predisposition - Role in therapy selection across tumor types – Siddhartha Yadav, MD
10:45 AM - 11:00 AM
Current targeted therapies for germline alterations in Breast Cancer – Melinda L. Telli, MD
11:00 AM - 11:15 AM
Future Pipeline Agents Targeting Germline DNA alterations in Cancer Medicine – Pamela Munster, MD
11:15 AM - 11:30 AM
An Academic Journey from Gene Discovery to First-in-Class FDA Approval for Familial and Sporadic Kidney Cancer – James Brugarolas, MD, PhD
11:30 AM - 11:45 AM
Panel Discussion
Moderators:
Pamela Munster, MD
Panelists:
Siddhartha Yadav, MD; Melinda L. Telli, MD; James Brugarolas, MD, PhD
Session Chair: James M. Ford, MD
11:45 AM - 12:00 PM
NHS-Galleri Trial – Elizabeth (Betsy) O' Donnell, MD
12:00 PM - 12:15 PM
Sensitive Detection of MRD in Early-stage Cancer – Milana v Dolezal, MD
12:15 PM - 12:30 PM
Controversies in Treatment-emergent Drug Resistance Mutations: Intervention Prior to RECIST Disease Progression – Pedram Razavi, MD PhD
12:30 PM - 01:00 PM
Panel Discussion
Moderators:
James M. Ford, MD
Panelists:
Elizabeth (Betsy) O' Donnell, MD; Milana v Dolezal, MD; Pedram Razavi, MD PhD
Session Chair: Arun Wiita, MD, PhD
02:00 PM - 02:15 PM
Novel ADC Linker/Payload Considerations – Mark Daniel Pegram, MD
02:15 PM - 02:30 PM
Therapeutic strategies targeting brain metastases – Nancy Lin, MD
02:30 PM - 03:00 PM
Panel Discussion
Moderators:
Arun Wiita, MD, PhD
Panelists:
Mark Daniel Pegram, MD; Nancy Lin, MD
Session Chair: James M. Ford, MD; Varun Monga, MD, MBBS
03:20 PM - 03:30 PM
Case Presentation – Constance Wu, MD (Fellow)
03:30 PM - 03:40 PM
Case Presentation – Margaret Guo, MD PhD
03:40 PM - 04:20 PM
Panel Discussion
Moderators:
Varun Monga, MD, MBBS; James M. Ford, MD
Panelists:
Constance Wu, MD (Fellow); Margaret Guo, MD PhD
Session Chair: Vivek Subbiah, MD
04:20 PM - 04:35 PM
Adaptive Feedback and Bypass Pathways – Trever Bivona, MD, PhD
04:35 PM - 04:50 PM
Mechanisms of ADC Resistance – Naoto Ueno, MD, FACP, PhD
04:50 PM - 05:20 PM
Panel Discussion
Moderators:
Vivek Subbiah, MD
Panelists:
Trever Bivona, MD, PhD; Naoto Ueno, MD, FACP, PhD
Day 2: Saturday, September 12th, 2026
Venue and map
Accreditations and continuing education
Acknowledgement of Commercial Support
This activity is supported with an Independent Medical Education grant from Gilead Sciences.
